Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Johnson and Johnson
McKinsey
Fuji
AstraZeneca
Farmers Insurance
Colorcon
Federal Trade Commission
Queensland Health

Generated: January 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Onartuzumab

« Back to Dashboard

US Patents for Onartuzumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Onartuzumab ➤ Try a Free Trial Multispecific constructs AbbVie Stemcentrx LLC (North Chicago, IL) ➤ Try a Free Trial
Onartuzumab ➤ Try a Free Trial Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Try a Free Trial
Onartuzumab ➤ Try a Free Trial P97 fragments with transfer activity biOasis Technologies, Inc. (Vancouver, British Columbia, unknown) ➤ Try a Free Trial
Onartuzumab ➤ Try a Free Trial Fragments of p97 and uses thereof biOasis Technologies, Inc. (Richmond, CA) ➤ Try a Free Trial
Onartuzumab ➤ Try a Free Trial Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Try a Free Trial
Onartuzumab ➤ Try a Free Trial Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients Corning Incorporated (Corning, NY) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Onartuzumab

Drugname Country Document Number Estimated Expiration Related US Patent
Onartuzumab Canada 2900764 2033-02-08 ➤ Try a Free Trial
Onartuzumab European Patent Office 2954056 2033-02-08 ➤ Try a Free Trial
Onartuzumab Hong Kong 1218930 2033-02-08 ➤ Try a Free Trial
Onartuzumab Japan 2016509014 2033-02-08 ➤ Try a Free Trial
Onartuzumab World Intellectual Property Organization (WIPO) 2014124326 2033-02-08 ➤ Try a Free Trial
Onartuzumab Australia 2012294673 2031-08-05 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Johnson and Johnson
McKesson
Farmers Insurance
QuintilesIMS
Queensland Health
Merck
Boehringer Ingelheim
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.